|
|
Potential Exposure to Certain Chemicals with Use of GE HealthCare EVair and EVair03 Compressors with Certain Ventilators – Letter to Health Care Providers
The FDA issued a Letter to Health Care Providers to alert providers and facilities about the potential for exposure to certain chemicals that may be released when General Electric (GE) Healthcare accessory components called the EVair or Evair03 compressor are used with certain ventilators, and to help ensure providers are aware of the manufacturer’s recall notice and recommended actions.
The Letter to Health Care Providers includes important information such as:
- Recommendations for health care providers and facilities.
- Actions that the FDA is taking to address the issue.
- Instructions for reporting problems with a device.
The FDA is committed to communicating with health care providers and the public, when needed, to help ensure the health and safety of patients in support of our mission to protect and promote public health.
Questions?
If you have questions about this letter to health care providers, contact the Division of Industry and Consumer Education (DICE).
|
|
|
|
